Compare Medtronic PLC (MDT) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Vertiv Holdings Co — how do they compare? Medtronic PLC trades at $88.02 (market cap $112.24B), while Vertiv Holdings Co trades at $245.67 (market cap $93.83B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Vertiv Holdings Co for 39 Days on average.
| MDT | VRT | |
|---|---|---|
Market Cap | $112.24B | $93.83B |
Volume | 105,663,236 | 5,855,911 |
Sector | Health | Industrials |
52-Week High | $105.35 | $376.23 |
52-Week Low | $73.75 | $149.83 |
Typical Hold Time | 63 Days | 39 Days |
Enterprise Value | $131.58B | $94.06B |
Dividend Yield | 3.28% | 0.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Vertiv (VRT) trades at $244.75, down 0.71% on the day, with a bearish technical signal from moving averages. The company shows strong fundamentals with Q2 2026 EPS beating estimates at $1.52 versus $1.42 expected, and robust profitability with a net income margin of 15.09% and ROE of 43.94%. Revenue growth is projected to increase from $10.23B in 2025 to $11.5B in 2026. Analyst sentiment remains overwhelmingly positive with a 95.24% buy rating and a consensus price target of $364.94, highlighting confidence in VRT's position in the AI data center infrastructure market.
The outlook for VRT is bullish based on strong earnings momentum and AI-driven demand for data center solutions, though high valuation ratios (P/E of 55.14) and a recent legal investigation pose risks. The stock offers significant upside to the consensus target, but investors should monitor competitive pressures and execution on growth forecasts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
